Simultaneous determination of diphenhydramine, its N-oxide metabolite and their deuterium-labeled analogues in ovine plasma and urine using liquid chromatography electrospray tandem mass spectrometry

Citation
S. Kumar et al., Simultaneous determination of diphenhydramine, its N-oxide metabolite and their deuterium-labeled analogues in ovine plasma and urine using liquid chromatography electrospray tandem mass spectrometry, J MASS SPEC, 33(12), 1998, pp. 1171-1181
Citations number
19
Categorie Soggetti
Chemistry & Analysis","Spectroscopy /Instrumentation/Analytical Sciences
Journal title
JOURNAL OF MASS SPECTROMETRY
ISSN journal
10765174 → ACNP
Volume
33
Issue
12
Year of publication
1998
Pages
1171 - 1181
Database
ISI
SICI code
1076-5174(199812)33:12<1171:SDODIN>2.0.ZU;2-#
Abstract
Oar studies on drug disposition in chronically instrumented pregnant sheep involve simultaneous administration of the antihistamine diphenhydramine (D PHM), its deuterated analogue ([H-2(10)]DPHM) and their metabolites to the mother or the fetus via various routes. Such studies require sensitive and selective mass spectrometric methods for quantitation of these labeled and unlabeled compounds in order to assess comparative maternal and fetal drug metabolism. The objective of this study was to develop and validate a liqui d chromatographic/tandem mass spectrometric (LC/MS/MS) method for the simul taneous quantitation of DPHM, its N-oxide metabolite and their deuterium-la beled analogues in ovine plasma and urine. Samples spiked with the analytes and the internal standard, orphenadrine, were processed using liquid-liqui d extraction. The extract was chromatographed on a propylamino LC column an d MS/MS detection was performed in the positive ion electrospray mode using multiple reaction monitoring, The linear concentration ranges of the calib ration curves for the N-oxides and the parent amines were 0.4-100.0 and 0.2 -250.0 ng ml(-1), respectively. In validation tests, the assay exhibited ac ceptable variability (less than or equal to 15% at analyte concentrations b elow 2.0 ng ml(-1) and <10% at all other concentrations) and bias (<15% at all concentrations), and the analytes were stable under a variety of sample handling conditions. Using this method, the labeled and unlabeled N-oxide metabolite was identified in fetal plasma after DPHM and [H-2(10)]DPHM admi nistration. This method will be used further to examine the comparative met abolism of;diphenhydramine to its N-oxide metabolite in the mother and the fetus. (C) 1998 John Wiley & Sons, Ltd.